Literature DB >> 34784045

Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma.

Frances Alexander1, Emily Brunt1, Holly Humphries1, Breeze Cavell1, Stephanie Leung1, Lauren Allen1, Rachel Halkerston1, Elodie Lesne1, Elizabeth Penn1, Stephen Thomas1, Andrew Gorringe1, Stephen Taylor2.   

Abstract

Complement is a key component of functional immunological assays used to evaluate vaccine-mediated immunity to a range of bacterial and viral pathogens. However, standardization of these assays is complicated due to the availability of a human complement source that lacks existing antibodies acquired either through vaccination or natural circulation of the pathogen of interest. We have developed a method for depleting both IgG and IgM in 200 mL batches from pooled hirudin-derived human plasma by sequential affinity chromatography using a Protein G Sepharose column followed by POROS™ CaptureSelect™ IgM Affinity resin. The production of large IgG- and IgM-depleted batches of human plasma that retains total hemolytic and alternative pathway activities allows for improved assay standardization and comparison of immune responses in large clinical trials.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Complement system; FPLC; Human plasma; IgG depletion; IgM depletion

Mesh:

Substances:

Year:  2022        PMID: 34784045     DOI: 10.1007/978-1-0716-1900-1_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  30 in total

1.  Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.

Authors:  S Romero-Steiner; D Libutti; L B Pais; J Dykes; P Anderson; J C Whitin; H L Keyserling; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

3.  Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.

Authors:  Jenny Herbert; Stephen Thomas; Charlotte Brookes; Claudia Turner; Paul Turner; Francois Nosten; Kirsty Le Doare; Michael Hudson; Paul T Heath; Andrew Gorringe; Stephen Taylor
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

4.  Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.

Authors:  Kelly Townsend; Shamez N Ladhani; Helen Findlow; Ray Borrow
Journal:  Vaccine       Date:  2014-08-17       Impact factor: 3.641

5.  Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies.

Authors:  Masanori Terajima; John Cruz; Mary Dawn T Co; Jane-Hwei Lee; Kaval Kaur; Jens Wrammert; Patrick C Wilson; Francis A Ennis
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

6.  Complement activation is required for induction of a protective antibody response against West Nile virus infection.

Authors:  Erin Mehlhop; Kevin Whitby; Theodore Oliphant; Anantha Marri; Michael Engle; Michael S Diamond
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

8.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae.

Authors:  Stephen R Thomas; Stephanie Leung; Katy Knox; Tom M A Wilkinson; Karl J Staples; Pascal Lestrate; Dominique Wauters; Andrew Gorringe; Stephen C Taylor
Journal:  BMC Microbiol       Date:  2018-10-29       Impact factor: 3.605

View more
  2 in total

1.  Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins.

Authors:  Stephen Findlay-Wilson; Linda Easterbrook; Sandra Smith; Neville Pope; Gareth Humphries; Holger Schuhmann; Didier Ngabo; Emma Rayner; Ashley David Otter; Tom Coleman; Bethany Hicks; Victoria Anne Graham; Rachel Halkerston; Kostis Apostolakis; Stephen Taylor; Susan Fotheringham; Amanda Horton; Julia Anne Tree; Matthew Wand; Roger Hewson; Stuart David Dowall
Journal:  Antiviral Res       Date:  2022-05-06       Impact factor: 10.103

2.  Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.

Authors:  Jack Mellors; Tom Tipton; Sarah Katharina Fehling; Joseph Akoi Bore; Fara Raymond Koundouno; Yper Hall; Jacob Hudson; Frances Alexander; Stephanie Longet; Stephen Taylor; Andrew Gorringe; N'Faly Magassouba; Mandy Kader Konde; Julian Hiscox; Thomas Strecker; Miles Carroll
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.